Mega Genomics Limited (HKG:6667)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.20
-0.05 (-0.69%)
Mar 31, 2025, 3:45 PM HKT

Mega Genomics Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
164.23151.3145.73237.19203.22
Revenue Growth (YoY)
8.54%3.82%-38.56%16.71%64.28%
Cost of Revenue
44.88636470.5156.98
Gross Profit
119.3588.381.72166.68146.24
Selling, General & Admin
59.4675.2177.7945.9535.4
Research & Development
19.17----
Other Operating Expenses
0.520.782.485.873.8
Operating Expenses
79.1562.01106.1357.9838.47
Operating Income
40.226.28-24.4108.69107.77
Interest Expense
-1.72-1.12-0.72-6.91-16.55
Interest & Investment Income
-6.074.012.980.34
Currency Exchange Gain (Loss)
-1.4411.75--
Other Non Operating Income (Expenses)
7.863.51-12.06-8.943.24
EBT Excluding Unusual Items
46.3436.18-21.4295.8294.8
Gain (Loss) on Sale of Investments
7.29--0.060.1
Pretax Income
53.6336.18-21.4295.8894.9
Income Tax Expense
8.596.14-3.816.8715.81
Net Income
45.0530.04-17.6279.0279.1
Net Income to Common
45.0530.04-17.6279.0279.1
Net Income Growth
49.96%---0.10%166.40%
Shares Outstanding (Basic)
205212206127-
Shares Outstanding (Diluted)
205212206127-
Shares Change (YoY)
-3.31%2.65%62.09%--
EPS (Basic)
0.220.14-0.090.62-
EPS (Diluted)
0.220.14-0.090.62-
EPS Growth
55.10%----
Free Cash Flow
-127.83-11.9226.47101.79
Free Cash Flow Per Share
-0.60-0.060.21-
Gross Margin
72.67%58.36%56.08%70.27%71.96%
Operating Margin
24.48%17.37%-16.75%45.83%53.03%
Profit Margin
27.43%19.85%-12.09%33.31%38.92%
Free Cash Flow Margin
-84.49%-8.18%11.16%50.09%
EBITDA
48.4534.54-16.08117.05116.31
EBITDA Margin
29.50%22.83%-11.03%49.35%57.23%
D&A For EBITDA
8.268.268.338.368.53
EBIT
40.226.28-24.4108.69107.77
EBIT Margin
24.48%17.37%-16.75%45.83%53.03%
Effective Tax Rate
16.01%16.97%-17.59%16.66%
Advertising Expenses
----14.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.